3M adds Singapore Lab

3M       PHARMACEUTICAL          MANUFACTURING

Singapore - 3M Drug Delivery Systems launched a new lab in Singapore yesterday that will cater to increasing demand for develop inhalers and skin patches in the Asia Pacific region.  

The new facility is sited in Yishun and joins 3M's existing Tuas and Woodlands plants. "Expanding our presence in Singapore will help us provide Asia Pacific customers with a product development service that has both local and global capabilities," said Jim Vaughan, VP and GM of 3M Drug Delivery Systems Division. "Our team in Singapore understands the region's regulatory requirements, and is able to quickly respond to customer needs."

The lab is the company's first contract research and development facility in the Asia Pacific region dedicated to pharmaceutical product development. It will be staffed with a team of chemists supported by 3M's global laboratory organisation, which has more than 50 years of experience in drug delivery.

Products produced in the lab will be suitable for manufacture in 3M's global network of manufacturing sites, and will be developed to conform to global standards, 3M said.

The company also said it plans to expand its Tuas plant to produce face masks for the Asia market to fulfil rising demand in the region. "What we're beginning to see in the literature is that asthma, respiratory diseases, and chronic obstructive pulmonary disease are on the increase in Asia," Vaughan said.

3M did not disclose the amount of investment in its new laboratory, but said its total investment in Tuas will cost some US$400 million.

________________________________________________________

Managing people? For HR and leadership strategy, Human Resources has it covered.

Get your marketing department up to speed with Asia's most read marketing site
marketing-interactive.com